cell:研究发现流感病毒致死机制

2011-09-22 MedSci原创 MedSci原创

       美国斯克里普斯研究所的科学家通过最新研究发现了流感病毒使感染者病重甚至死亡的机制。相关研究发表在9月16日出版的《细胞》杂志上。        研究人员将这种流感致死的免疫过程称为“细胞因子风暴”,可以预测病毒感染过程的发病率和死亡率,其被认为是1918-

       美国斯克里普斯研究所的科学家通过最新研究发现了流感病毒使感染者病重甚至死亡的机制。相关研究发表在9月16日出版的《细胞》杂志上。
 
       研究人员将这种流感致死的免疫过程称为“细胞因子风暴”,可以预测病毒感染过程的发病率和死亡率,其被认为是1918-1919 年间世界大流感和近来猪流感、禽流感爆发的主因。
 
       在这篇论文中,研究人员利用遗传学和化学手段研究细胞表面受体S1P1。他们意外地发现当控制血管壁内皮细胞的S1P1受体时,会影响细胞因子的释放。而之前科学家猜想细胞因子释放是通过位于肺部的受病毒侵染细胞发生的。
 
       NIH的詹姆斯M ·安德森博士表示,此项工作极大地提高了人们对“细胞因子风暴”生物基础的认识,打开了研发这种致命疾病新疗法的大门。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1868432, encodeId=8a3f186843273, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Dec 20 09:26:00 CST 2011, time=2011-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958645, encodeId=eed319586451a, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Jan 19 11:26:00 CST 2012, time=2012-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752941, encodeId=527c1e52941b8, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Nov 29 05:26:00 CST 2011, time=2011-11-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1868432, encodeId=8a3f186843273, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Dec 20 09:26:00 CST 2011, time=2011-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958645, encodeId=eed319586451a, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Jan 19 11:26:00 CST 2012, time=2012-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752941, encodeId=527c1e52941b8, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Nov 29 05:26:00 CST 2011, time=2011-11-29, status=1, ipAttribution=)]
    2012-01-19 维他命
  3. [GetPortalCommentsPageByObjectIdResponse(id=1868432, encodeId=8a3f186843273, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Dec 20 09:26:00 CST 2011, time=2011-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958645, encodeId=eed319586451a, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Jan 19 11:26:00 CST 2012, time=2012-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752941, encodeId=527c1e52941b8, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Tue Nov 29 05:26:00 CST 2011, time=2011-11-29, status=1, ipAttribution=)]